Announced Sat, 3 Oct, 2026 · 18:46 IST
Board okays about 9x authorised capital hike, alters objects, appoints CS
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Board of Hemo Organic on 3 Oct 2026 approved: (1) altering main objects to add diamond trading, cutting, real estate and investment activities; (2) raising authorised share capital from Rs 13.45 crore to Rs 125 crore, roughly 9.3 times; (3) appointing Ms Pratibha Sharma as Company Secretary and Compliance Officer. Fund raising proposal deferred to a later board meeting. All changes need shareholder approval.
Likely market impact
Big jump in authorised capital and new business areas point to possible fund raise and diversification ahead, but nothing takes effect until shareholders approve.